arrow
J

Jessica Dyson

University of Leeds
H指数:35
被引数:4,993

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The ethics of unlicensed therapy use in primary biliary cholangitis: a counter view

未经许可疗法在原发性胆汁性胆管炎中的伦理考量:一种对立观点

2026-02-190
PRE
Monitoring and advanced therapies in patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: a RAND appropriateness panel

对原发性硬化性胆管炎和炎症性肠病患者进行监测和先进治疗:一项RAND适宜性专家小组研究

2026-01-010
PRE
Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis

肝硬度测量的预后价值与生化反应在原发性胆汁性胆管炎中的比较

2025-10-030
PRE
Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis

对奥贝胆酸的非应答与原发性胆汁性胆管炎患者发生临床事件的风险增加相关

2025-09-220
OAAI
Implementation of a care bundle improves PBC management

实施护理方案可改善PBC管理

2025-04-100
OAAI
Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis

肝脏硬度测量的动力学和原发性胆汁性胆管炎的临床过程

2024-12-011
OAAI
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?

原发性胆汁性胆管炎药物评估和监管批准: 我们从这里走向何方?

2024-03-226
OAAI
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?

在原发性胆汁性胆管炎中对熊去氧胆酸的充分反应与深度反应: 正常碱性磷酸酶水平在多大程度上和在什么条件下与无并发症生存率增加相关?

2023-07-0323
OA
UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis

英国范围内对原发性胆汁性胆管炎二线治疗的多中心评估

2023-06-0117
OA
Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis

与原发性胆汁性胆管炎对熊去氧胆酸治疗反应不足相关的细菌和代谢表型

2023-05-1612
OAAI
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis

通过振动控制的瞬时弹性成像测量肝脏硬度可改善原发性胆汁性胆管炎的预后预测

2022-12-0147
OAAI